| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 274.11 | 9.8% | 3.4% |
| Total Income | 274.11 | 9.8% | 3.4% |
| Expenditure | 194.44 | 9.4% | 2.5% |
| PBT | — | ||
| Net Profit | 42.21 | 11.1% | 22.4% |
| OPM | 29.07% | 0.31pp | 0.65pp |
| NPM | 15.40% | 3.62pp | 3.76pp |
| EPS | 0.86 | 10.4% | 21.8% |
Prestige Consumer Healthcare Announces Q1 FY26 Results
04 May 2026 · 4 May, 7:43 am
Summary
Prestige Consumer Healthcare Inc. announced its financial results for the fiscal quarter and six months ended September 30, 2025. The company's representatives began investor presentations regarding these results. The company intends to use the investor presentation, possibly with modifications, for presentations throughout the fiscal year ending March 31, 2026.
Key Highlights
- 1
Prestige Consumer Healthcare Inc. announced financial results for the fiscal quarter and six months ended September 30, 2025.
- 2
The company's earnings results for the fiscal quarter and six months ended September 30, 2025 are detailed in the attached press release.
- 3
Representatives of the Company began making presentations to investors regarding the Company's financial results for the quarter and six months ended September 30, 2025.
- 4
The Company expects to use the Investor Presentation in connection with presentations to investors, analysts and others during the fiscal year ended March 31, 2026.
Informational and educational content only. Not investment advice.